Loading
Latest filing published 01 Jun 2018 for Sonoma Pharmaceuticals, Inc..
No signal scores available.
Jay E. Birnbaum appears in our data through filings on Sonoma Pharmaceuticals, Inc. shares, published by SEC (Form 4). In total, 13 filings cover trades dated from 29 February 2016 to 30 May 2018.
None of the filings is a plain purchase or sale on the open market; they cover grants, option exercises and other movements. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.
On 1 June 2018 came the latest disclosure, a share grant in Sonoma Pharmaceuticals, Inc. Filings reach the SEC (Form 4) feed a median of 1 day after the trade. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
13 of 13 declarations